We recently published a list of 20 Stocks Insiders Bought in April After Trump’s Tariff Rollout. In this article, we are going to take a look at where Owens & Minor, Inc. (NYSE:OMI) stands against other stocks that insiders bought in April after Trump’s tariff rollout.
President Donald Trump called April 2 a “Liberation Day” after signing an executive order that imposed a minimum 10% tariff on all U.S. imports, with some exceptions. As a result, 57 countries will face higher tariffs ranging from 11% to 50%. While general tariffs took effect on April 5, the elevated rates are set to begin on April 9. These so-called ‘reciprocal tariffs’ triggered retaliation from trade partners and contributed to a decline in the stock market.” On Sunday, Trump said, “I don’t want anything to go down, but sometimes you have to take medicine to fix something,” as reported by CNBC.
The blue-chip companies closed the Monday market session 0.91% lower, while the broader market index closed 0.23% lower after briefly entering bear market territory during the session. The Nasdaq Composite closed 0.10% higher.
Amid these tariff wars and overwhelming market uncertainty, insider trading often comes to focus. Why? When executives buy stock, it can suggest confidence in the company’s future. On the other hand, insider sales don’t have to be a negative sign for the company, because they can reflect personal decisions or investment diversification. This means that insider trading should be considered alongside the company’s financial health and market conditions.
Our Methodology
Today, we’re focusing on stocks that insiders have been buying in April. Using Insider Monkey’s insider trading screener, we identified companies where at least one insider acquired shares from April 2 to April 7. From this list, we ranked the top 20 stocks with the highest value of insider purchases.
Our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds, focusing on insider trading and stock picks from hedge fund investor newsletters and conferences. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
A medical professional in a hospital wearing protective apparel supplied by the healthcare solutions company.
Owens & Minor, Inc. (NYSE:OMI)
Owens & Minor, Inc. (NYSE:OMI) is a healthcare solutions company that provides medical products and services to healthcare providers worldwide. It operates in two segments: Products & Healthcare Services, offering medical supplies and services, and Patient Direct, delivering in-home care products for conditions like diabetes and sleep apnea.
In April, one insider acquired approximately $4.29 million worth of Owens & Minor shares at an average price of $8.17 per share. The stock now trades at $8.13 having lost 37.80% year-to-date, and 70.13% over the past 12 months.
For the full year 2024, Owens & Minor (NYSE:OMI) reported revenue of $10.70 billion, compared to revenue of $10.33 billion in 2023. Net loss was $363 million, compared to net loss of $41 million in the prior year. Adjusted EBITDA was a gain of $523 million, compared to adjusted EBITDA of $526 million in 2023.
According to TipRanks, five Wall Street analysts rate Owens & Minor (NYSE:OMI) stock as a “Hold” with a price target of $10.72 per share. The average price target suggests a 31.86% upside from the latest price.
Overall, OMI ranks 7th on our list of stocks that insiders bought in April after Trump’s tariff rollout. While we acknowledge the potential of OMI, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than OMI but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.
